Hearing the word glioblastoma can raise many questions. This guide introduces the condition and helps you prepare for conversations with the care team. Medical decisions need to be based on each person’s circumstances and clinical records.
What is glioblastoma?
Glioblastoma, often called GBM, is a fast-growing malignant tumour in the glioma family that begins in the brain. Its cells can grow into surrounding tissue. Not every brain mass is glioblastoma; the exact diagnosis in the pathology report matters. [1]
How is the diagnosis established?
Assessment usually begins with the medical history, a neurological examination, and imaging such as MRI. Identifying the tumour type generally involves examining tissue obtained through surgery or a biopsy. The clinical team assesses whether sampling is safe and feasible, considering the tumour’s location and the patient’s condition. [1]
Molecular testing of the tissue can help refine the diagnosis and inform treatment decisions. Ask which tests have been performed, what their results mean, and whether further testing is needed. [2]
How is treatment planned?
Treatment may include surgery to remove as much of the tumour as is safely possible, followed by radiotherapy and chemotherapy. The combination and sequence are not the same for everyone. The tumour’s location, tissue findings, the patient’s overall health, and goals of care inform the plan. [1] [3]
Ask the care team to explain the aim of each step, its expected benefit, possible side effects, and the follow-up plan. Before leaving an appointment, make sure you know what happens next and whom to contact with questions or changes in the patient’s condition.
Everyday life is part of care
Symptoms, comfort, emotional strain, and family needs deserve a place in treatment discussions. Palliative care can be provided alongside treatment to help with physical and emotional difficulties. Ask the care team about support that is appropriate and available to you. [4]
Research and clinical trials
Clinical trials address specific questions about treatment and care. Whether a study is suitable depends on its eligibility criteria and the individual’s circumstances; taking part does not guarantee a better treatment outcome. Ask about the study’s purpose, alternatives, risks, costs, and required visits. [5]
Participation should be informed and voluntary. Read the study information and consent form before deciding, and ask the research team about anything unclear. The option to withdraw is also part of the informed consent discussion. [6]
Questions for your next appointment
- What is the full diagnosis, and what has the tissue report established?
- Have the relevant molecular tests been completed, and how do they affect treatment decisions?
- What is the aim and plan for the next step, and when should it happen?
- What support is available for symptoms and quality of life?
- Is there a relevant clinical trial that would be appropriate to consider?
Sources and further reading
The medical information on this page draws on resources from the US National Cancer Institute (NCI).
- Adult Central Nervous System Tumors Treatment
- How Brain Tumors Are Diagnosed and Treated
- Central Nervous System Tumors Treatment — Health Professional Version
- Palliative Care in Cancer
- Why Participate in a Clinical Trial?; What to Expect During a Clinical Trial
- Understanding Informed Consent Forms
Sources last checked:
